291 related articles for article (PubMed ID: 20666852)
41. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
[TBL] [Abstract][Full Text] [Related]
42. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
43. BCR-ABL1-like B-lymphoblastic leukemia/lymphoma: Review of the entity and detection methodologies.
Conant JL; Czuchlewski DR
Int J Lab Hematol; 2019 May; 41 Suppl 1():126-130. PubMed ID: 31069976
[TBL] [Abstract][Full Text] [Related]
44. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.
Boldt DH; Kopecky KJ; Head D; Gehly G; Radich JP; Appelbaum FR
Leukemia; 1994 Dec; 8(12):2118-26. PubMed ID: 7807999
[TBL] [Abstract][Full Text] [Related]
45. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
[TBL] [Abstract][Full Text] [Related]
46. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
47. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
48. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G
Leukemia; 2010 Jan; 24(1):66-73. PubMed ID: 19759560
[TBL] [Abstract][Full Text] [Related]
49. [Acute lymphocytic leukemia with Philadelphia chromosome and rearrangements of bcr gene and deletion of 5' side and of TCR-delta gene].
Ohnishi A; Kagiyama S; Shintate Y; Kimura N; Ohgami A; Takechi M; Tanaka K; Kamada N
Rinsho Ketsueki; 1990 Jun; 31(6):820-6. PubMed ID: 2145450
[TBL] [Abstract][Full Text] [Related]
50. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
Orfao A; Chillón MC; Bortoluci AM; López-Berges MC; García-Sanz R; Gonzalez M; Tabernero MD; García-Marcos MA; Rasillo AI; Hernández-Rivas J; San Miguel JF
Haematologica; 1999 May; 84(5):405-12. PubMed ID: 10329918
[TBL] [Abstract][Full Text] [Related]
51. Monitoring of childhood ALL using
Hovorkova L; Zaliova M; Venn NC; Bleckmann K; Trkova M; Potuckova E; Vaskova M; Linhartova J; Machova Polakova K; Fronkova E; Muskovic W; Giles JE; Shaw PJ; Cario G; Sutton R; Stary J; Trka J; Zuna J
Blood; 2017 May; 129(20):2771-2781. PubMed ID: 28331056
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.
Roberts KG; Pei D; Campana D; Payne-Turner D; Li Y; Cheng C; Sandlund JT; Jeha S; Easton J; Becksfort J; Zhang J; Coustan-Smith E; Raimondi SC; Leung WH; Relling MV; Evans WE; Downing JR; Mullighan CG; Pui CH
J Clin Oncol; 2014 Sep; 32(27):3012-20. PubMed ID: 25049327
[TBL] [Abstract][Full Text] [Related]
53. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
[TBL] [Abstract][Full Text] [Related]
54. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
Kurita D; Hatta Y; Hojo A; Kura Y; Sawada U; Kanda Y; Takei M
Cancer Genet; 2016 Apr; 209(4):161-5. PubMed ID: 26854094
[TBL] [Abstract][Full Text] [Related]
55. Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
Chiaretti S; Messina M; Grammatico S; Piciocchi A; Fedullo AL; Di Giacomo F; Peragine N; Gianfelici V; Lauretti A; Bareja R; Martelli MP; Vignetti M; Apicella V; Vitale A; Li LS; Salek C; Elemento O; Inghirami G; Weinstock DM; Guarini A; Foà R
Br J Haematol; 2018 Jun; 181(5):642-652. PubMed ID: 29675955
[TBL] [Abstract][Full Text] [Related]
56. Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals.
Abou Mourad YR; Bhargava R; Bruyère H; Gillian T; Barnett MJ; Forrest DL; Nevill TJ; Toze CL; Nantel SH; Shepherd JD
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):281-6. PubMed ID: 23098889
[TBL] [Abstract][Full Text] [Related]
57. Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia.
Boer JM; Steeghs EM; Marchante JR; Boeree A; Beaudoin JJ; Beverloo HB; Kuiper RP; Escherich G; van der Velden VH; van der Schoot CE; de Groot-Kruseman HA; Pieters R; den Boer ML
Oncotarget; 2017 Jan; 8(3):4618-4628. PubMed ID: 27894077
[TBL] [Abstract][Full Text] [Related]
58. A near-haploid clone harboring a BCR/ABL1 gene fusion in an adult patient with newly diagnosed B-lymphoblastic leukemia.
Peterson JF; Ketterling RP; Huang L; Finn LE; Shi M; Hoppman NL; Greipp PT; Baughn LB
Genes Chromosomes Cancer; 2019 Sep; 58(9):665-668. PubMed ID: 30790375
[TBL] [Abstract][Full Text] [Related]
59. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.
Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M
Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810
[TBL] [Abstract][Full Text] [Related]
60. CD25 Expression in B Lymphoblastic Leukemia/Lymphoma Predicts t(9;22)(q34;q11)/Philadelphia Chromosome Translocation (Ph) and Is Associated With Residual Disease in Ph-Negative Patients.
Chen P; Chu A; Zia H; Koduru P; Collins R; Winick N; Fuda F; Chen W
Am J Clin Pathol; 2016 Nov; 146(5):632-638. PubMed ID: 28430957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
